The role of cell therapies and hip arthroscopy in the management of osteonecrosis: an update
- PMID: 30393546
- PMCID: PMC6206693
- DOI: 10.1093/jhps/hny021
The role of cell therapies and hip arthroscopy in the management of osteonecrosis: an update
Abstract
The exact pathophysiology of osteonecrosis of the femoral head (ONFH) is still unknown. There is evidence to suggest that in ON there is decreased population and altered function of the mesenchymal stem cells (MSCs) of the femoral head. This could influence both the actual occurrence of ON itself and the repair process that follows. Hence, in such an environment it only is rational to consider the use of cell-based treatments to potentially regenerate lost or damaged bone. The aim of this review is to provide an up-to-date, evidence-based information in the use of cell therapies in the treatment of nontraumatic ONFH and the use of hip arthroscopy in the field.
Figures
References
-
- Lieberman JR, Berry DJ, Mont MA. et al. Osteonecrosis of the hip: management in the 21st century. Instr Course Lect 2003; 52: 337–55. - PubMed
-
- Mont MA, Zywiel MG, Marker DR. et al. The natural history of untreated asymptomatic osteonecrosis of the femoral head: a systematic literature review. J Bone Joint Surg Am 2010; 92: 2165–70. - PubMed
-
- Piuzzi NS, Chahla J, Schrock JB. et al. Evidence for the use of cell-based therapy for the treatment of osteonecrosis of the femoral head: a systematic review of the literature. J Arthroplasty 2017; 32: 1698–708. - PubMed
-
- Chughtai M, Piuzzi NS, Khlopas A. et al. An evidence-based guide to the treatment of osteonecrosis of the femoral head. Bone Joint J 2017; 99-B: 1267–79. - PubMed
-
- Mont MA, Cherian JJ, Sierra RJ. et al. Nontraumatic osteonecrosis of the femoral head: where do we stand today? A ten-year update. J Bone Joint Surg 2015; 97: 1604–27. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
